FiercePharma

FDA Approves First Generic Enoxaparin Sodium Injection to Prevent DVT

The U.S. Food and Drug Administration today approved the first generic version of Lovenox (enoxaparin sodium injection), an anti-coagulant drug used to prevent deep vein thrombosis (DVT), a ...
International Business Times

Enoxaparin Recall: Mislabeled Injectable Blood Thinner Could Result In 'Inaccurate Dose Administration'

Apotex recalled two batches of mislabeled enoxaparin sodium syringes Enoxaparin is used to prevent blood clots It should not be stopped without doctors' advice A pharmaceutical company is recalling ...
Monthly Prescribing Reference

Packaging Error Prompts Recall of Enoxaparin Sodium Injection

Patients exposed to a higher dose may be subject to bleeding complications. Apotex Corp announced the voluntary recall of 2 batches of Enoxaparin Sodium Injection ...
Nasdaq

Sandoz Recalls One Lot Of Enoxaparin Sodium Injection

(RTTNews) - Sandoz, Inc., an unit of Novartis Pharma AG, is recalling one lot of deep vein thrombosis (DVT) medication Enoxaparin Sodium in the form of injection for the potential exposure to high ...
PharmiWeb

Techdow USA Announces Launch of its Generic Lovenox®, (Enoxaparin Sodium – Preservative Free) in Prefilled Syringes

LANGHORNE, Pa.--(BUSINESS WIRE)--#Enoxaparin--Techdow USA Inc. (“Techdow USA”), a growing market leader and vertically integrated generic injectables company, today announced the launch of its 30mg, ...
Miami Herald

A South Florida company recalls a blood clot drug nationally after a dangerous mistake

Syringe marking errors, which can lead to incorrect dosing, caused a recall of Enoxaparin Sodium Injection, a generic version of blood clot medication Lovenox. The recall issued Tuesday by Apotex, a ...
Drug Store News

Sandoz first to receive FDA approval for Lovenox generic

SILVER SPRING, Md. The Food and Drug Administration has approved the first generic version of a Sanofi-Aventis injected drug used to treat deep vein thrombosis, the agency said Friday. The FDA ...
The Daily Star

M-Enoxaparin ANDA not approvable in current form

Momenta Pharmaceutics Inc. (Nasdaq:MNTA) announced that its collaboration partner, Sandoz Inc. (Sandoz), a division of Novartis, had received a letter from the U.S. Food and Drug Administration (FDA) ...
FiercePharma

Sanofi-aventis expresses concern over the approval of another version of enoxaparin sodium in the U.S.

Sanofi-aventis expresses concern over the approval of another version of enoxaparin sodium in the U.S. Paris, France - July 23, 2010 - Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) has reservations on ...
Business Wire

Meitheal Pharmaceuticals Announces FDA Approval of Enoxaparin Sodium Injection, USP in the United States

CHICAGO--(BUSINESS WIRE)--Meitheal Pharmaceuticals, Inc. (“Meitheal”), a fully integrated generic injectables company today announced that the US Food and Drug Administration (FDA) has approved ...
Medscape

Dabigatran Etexilate: A Novel Oral Direct Thrombin Inhibitor

Am J Health Syst Pharm. 2011;68(16):1506-1519. The higher rate of myocardial infarction seen in the dabigatran groups is concerning. It is unclear what caused the increased rate of myocardial ...
Medscape

FDA Approves First Generic Enoxaparin Injection

July 26, 2010 — The US Food and Drug Administration (FDA) has approved the first generic formulation of enoxaparin sodium injection (Sandoz, Inc; brand name, Lovenox; Sanofi-Aventis US, LLC), a ...